Search

Chilblain-like lesions (CLL) were described early on the coronavirus disease 2019 (COVID-19) pandemic as red-to-violet macules, plaques or nodules typically appearing at the distal aspects of toes.1 Although increasing evidence suggests they are COVID-19-related,2 it is not supported by analytic controlled studies. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? T-cell responses are more common than circulating antibodies in mild and asymptomatic COVID-19 patients. [Extracted from the article]

We have read with great interest the article: Cutaneous manifestations in COVID-19: a first perspective by Recalcati S.[1] This article is the first report of the cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Lombardy, Italy. Every medical and surgical specialty was integrated in this unit to provide assistance in the medical wards, overcrowded with COVID-19 patients. From a 1099 cohort of confirmed COVID-19 patients, only 2 presented "skin rash" without any further description.[5] Dermatologists have a unique opportunity to make our contribution during this pandemic and adequately describe skin manifestations of COVID-19. [Extracted from the article]